Conference - Events

Critical Issues America2026 Annual Conference - February 6-7, 2026We invite you to attend our annual CRITICAL ISSUES america (CIA) meeting. The meeting will help participants to identify and manage complications associated with endovascular and open repair of complex aortic disease including: arch descending thoracic, TAAA, pararenal and juxtarenal aneurysms, aortoiliac aneurysms and other miscellaneous pathologies affecting the aorta. CIA will recognize potential treatment failure and the role of advance imaging techniques in the evaluation, treatment, and management of aortic disease. The target audience includes physicians who specialize in vascular surgery, cardiology, interventional radiology, vascular medicine, cardiothoracic surgery, as well as fellows, and allied health professiona…

Innovating Novel Combination Therapies and Maximising Preclinical and Clinical Development to Improve Glioblastoma Targeting and Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in NeedThe glioblastoma drug development space has been energized by Merck's acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged by limited investment and clinical breakthroughs. Looking ahead to 2026, it's crucial to sustain this momentum. The 7th Glioblastoma Drug Development Summit is your essential platform for accelerating new treatments and continuing this vital progress. Join us for a definitive, 3-day summit designed to accelerate progress. With groundbreaking content and six deep-dive workshops, you'll connec…

The 20th Clinical Research Billing Compliance Summit brings together compliance officers, billing specialists, and research leaders to share strategies, updates, and best practices for accurate, audit-ready billing. Learn from experts, join workshops, and network with peers February 23-25, 2026 in New Orleans. Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Clinical Date and Time: 23rd February 2026 at 9:00 am to 25th February 2026 at 5:00 pm Venue details: New Orleans Marriott Warehouse Arts District, 859 Convention Center Boulevard, New Orleans, Louisiana, 70130, United States

About NEURO 2026 We are delighted to welcome you to the 4th European Congress of Neurology and Neuropsychiatry (Earn CME/CPD Credits) which will take place on February 23-24, 2026 in Paris, France. Neurology Conference 2026 will bring together leading neurologists, neuropsychiatrists, researchers, and healthcare professionals from around the globe to discuss the latest developments in neurology, psychiatry, and brain health.   Building upon the resounding success of the 2nd European Congress held in London, UK and 3rd European Congress held in Amsterdam, Netherlands we are eager to continue the tradition of fostering collaboration, knowledge exchange, and innovation in the field of neurology and neuropsychiatry. Amsterdam, with its rich history, cult…

Uniting 100+ leaders from cutting-edge biotechs to global pharma, this summit delivers comprehensive insight across antigen selection, biomarker strategy, B-cell and cellular tolerance mechanisms, delivery platforms, and clinical trial execution. The 2026 agenda spotlights late-stage data from Topas, Diamyd, and COUR; novel mRNA- LNP approaches from Moderna; integrated nanotherapeutics; and next-generation Treg and tolerance-restoring strategies. Key sessions explore central versus peripheral tolerance, and how gene and cell therapy are redefining therapeutic durability and safety. Now in its ninth year, the 9th Antigen-Specific Immune Tolerance Summit remains the only end-to-end meeting dedicated to advancing antigen-specific immune tolerance. Join Pfizer, Moderna, AbbVie, Diamyd, COUR, a…

SAE Media Group's AI in Drug Discovery 2026 takes place 9–10 March in London. Join pharma and biotech leaders to explore how AI, ML, and generative tools are transforming drug pipelines. The agenda features case studies, clinical updates, and expert panels on target ID, computational design, and scaling AI across R and D. Discover the latest breakthroughs and connect with directors and heads of informatics, molecular design, and data science.   Date and Time: On Monday March 09, 2026 at 8:30 am to Tuesday March 10, 2026 at 6:00 pm Venue details: Hilton London Kensington, 179-199 Holland Park Avenue, London, England, W11 4UL, United Kingdom

The 6th TPD and Induced Proximity Summit Europe is the only European forum dedicated exclusively to proximity-based drug discovery. From PROTACs and molecular glues to stabilizers and extracellular degraders, this summit showcases the full spectrum of therapeutic innovation across oncology, neurodegeneration, immunology, and rare diseases. Held in London in March 2026, the event brings together more than 80 CxOs, directors, senior scientists and investors to accelerate proximity therapeutics from discovery to clinic. Europe is experiencing a surge in strategic investment and innovation, including Sanofi’s acquisition of Blueprint Medicines for £7.2 billion and Merck’s £2.7 billion purchase of SpringWorks Therapeutics. As the region pivots toward non-oncology indications and novel mechanism…

Dear Colleagues It is our pleasure to welcome you to the 19th International Conference on Advanced Technologies and Treatments (ATTD 2026) taking place at the fascinating city of Barcelona, on March 11-14, 2026. Join us at ATTD 2026, the premier international platform where a diverse community - clinicians, diabetes care providers, researchers, industry, startups, investors, reimbursement authorities, and regulators - collaborates to drive rapid progress in diabetes care. The conference program features presentations and discussions led by distinguished professionals, covering a wide spectrum of innovations from artificial intelligence and glucose technology to novel therapies and prevention strategies. We look forward to your contributions and active participation, which will be instrumen…

The Marcus Evans 16th Edition R&D Controlling and Performance Management conference taking place in Amsterdam, Netherlands on 16-18 March, 2026 will tackle into some of the toughest challenges R&D controllers face today: securing funding for projects with uncertain outcomes, making the intangible value of innovation visible, and balancing transparency with the freedom researchers need to create. This conference will guide you through practical tools and real scenarios to transform uncertainty into actionable choices. You’ll learn how to build flexible budgets that withstand change, translate innovation into business value executives can back, and confidently sell R&D as a strategic growth driver.  Attending this premier Marcus Evans conference will enable you to:• Win the…

Healthcare is changing faster than we can reactCompanies have had to make billion-dollar bets on AI, manufacturing, organizational models and CRM systems, going against decades of waiting for clarity before committing. But clarity isn't coming, and patients can't wait. Nor can we. It's time to stop predicting the future and prepare for all futures. What works across all of them? Patient-centricity and cross-functionality. Cross-functionality unlocks trapped capabilities. Functional excellence without structural integration fails in today's efficiency-first world. When Medical and Commercial align, omnichannel delivers and launches accelerate. Coordination that consumed months compresses into days. World-class skills finally operate at world-class velocity, built on the technology stacks an…

Novel conjugates have become one of the most competitive and rapidly evolving areas in the precision oncology landscape. Companies are looking beyond traditional ADCs towards novel mechanism of action payloads and differentiated targeting formats for overcoming drug resistance, improved therapeutic windows and to make an impact in cancers which don’t respond to traditional ADCs, as well as the exploration of non-oncology indications. The 5th Novel Conjugates Summit is the industry’s only dedicated meeting for an insider view into which novel approaches are currently being explored, what benefit each approach has and the directions the space is heading. Attendees gain valuable competitive insight into emerging technologies, early data, and the rationale behind each approach, from establishe…

The Annual Pharma Supply Chain & Security World Summit is back in London for the 8th time, and this time with more focus on optimising your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance…

The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment. Key Topics Include:  Transform S&OP into IBP to Connect Strategy, Finance, and Execution Cross Functional Collaboration – Key for Successful S&OP/IBP Balance Short- and Long-Term Planning to Enable Strategic Alignment Leverage AI and Data to Strengthen S&OP and IBP Foundations Drive Change Management to Advance S&OP and IBP Maturity Align Portfolio and Demand to Build a Single Planni…

Join leading experts at the Pediatrics and Neonatology Conference to explore the latest advancements in child healthcare, pediatric research, and neonatal medicine. The event covers innovative treatments, clinical practices, and emerging pediatric technologies.

The 8th CRISPR AgBio Congress is the leading forum for AgBiotech innovators, seed companies, growers, consumer food brands, and investors to accelerate the commercialization of gene-edited crops. With USDA easing regulatory pathways and AI revolutionizing trait discovery, now is the time to position your organization at the forefront of sustainable agriculture. Join industry leaders, including Pairwise, Corteva, Bayer Crop Science, BASF, and more to explore next-generation CRISPR tools, AI-driven target discovery, and strategies for navigating global regulations. New for 2026: Global Regulations and IP Focus Day, a dedicated Driving Consumer Acceptance Panel, and expanded sessions on AI applications in AgBio. Be part of the only event combining technical breakthroughs with commercial know-…

The 11th Innate Killer Summit continues its legacy as the world's leading industry meeting dedicated exclusively to advancing NK and innate immune cell therapies. This year, the summit unites pioneering biotechs, including NKGen, NKILT, Senti Bio, NKore, and leaders from the MD Anderson Rizvani Lab, alongside translational scientists and platform innovators to showcase breakthrough progress in engineering, manufacturing, persistence, tumor targeting, and clinical translation. As the NK space becomes increasingly competitive and the path to differentiation narrows, this summit stands firmly alongside the global NK community, providing the clarity, collaboration, and momentum needed to keep innovation moving forward. With in-depth scientific content, real-world clinical insights across six c…

Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams who remain steadfast in their belief that this science can transform lives. Confidence is returning, with significant investments and acquisitions signalling a renewed commitment to overcoming barriers of safety, efficacy, and scalability. The 9th Gene Therapy Development Summit returns to Boston as the meeting point for this community. Join 100+ leading voices from the likes of Bayer, Astellas Pharmaceuticals, REGENXBIO, Ocugen, AskBio, CureDuchenne Ventures, and more to come together to share ideas, restore confidence, and chart a sustainable path forward for gene therapy. Connect with your peers in pre-clinical development, manufacturing, analy…

CMAC Open Days 2026: Join us 24–26 March 2026 as we celebrate 15 years of CMAC transforming medicines manufacturing. Discover how Industry 5.0 technologies are shaping the future of medicines manufacturing, with insights into the latest trends, tools, and strategies for creating future-ready, resilient and sustainable manufacturing processes. At the Open Days you’ll: 🤝 Network with top academics, industry leaders, and researchers 👩‍🔬 Engage in interactive sessions, lab tours, and poster presentations 💊 Learn about the latest innovations tackling real-world pharmaceutical challenges 🎟️ Registration is now open! Take advantage of early bird rates available until Monday 2 February 2026: £100 standard (rising to £125 after early bird) £80 PhD student (rising to £90 after early bird)

To,    I have reached out to you as your research areas/products/services are related to our upcoming conference. Considering the same, our organizing committee would like to invite to be a part of it and you will be a great fit for our upcoming “World Congress on Advances in Applied Science and Engineering” held during 25-26 March 2026. at London, United Kingdom   The WASE 2026 aims to bring together leading researchers, academicians, industry professionals, and policymakers to share innovations, exchange ideas, and foster collaboration across a wide range of topics. We extend warm invitation to you and your organization to be a part of the conference as a Sponsors/Exhibitor/Speaker/Delegate.   Let me know your interest in the same, accordingly I will share y…